HeyJaredDelilah Alvarado
- Indexed articles, last 90 days
- 3
- Latest publication
- Sep 30, 2026
- Outlet visibility, for BioPharma Dive
- Top 1M sites
- Earliest in this view
- Jul 6, 2026
Latest articles
FDA starts review of Roche’s multiple sclerosis pill (opens the original)
Read excerpt
The FDA previously hadn’t ever accepted an application of a drug like fenebrutinib in two major forms of MS. But safety questions still hang over Roche’s program. Fenebrutinib is among a class of drugs known as BTK, or Bruton’s tyrosine kinase, inhibitors. Earlier versions of these therapies initially came to market as cancer treatments. Newer prospects are now being tested against a range of autoimmune disorders. So far, research has produced somewhat mixed results. Novartis’ Rhapsido and Sanof
BioNTech taps Sobi executive Oelkers as its next CEO (opens the original)
Read excerpt
Guido Oelkers will guide BioNTech’s ongoing transition into an oncology-focused biotech, while co-founder and longtime leader Ugur Sahin prepares to join a fledgling mRNA startup.
Novartis to acquire ADC developer in a deal worth up to $1.5B (opens the original)
Read excerpt
The deal hands over two ADCs with a different mechanism of action targeting cell growth, and marks Novartis' entry into ADC development.
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
Top 1M sites
For BioPharma Dive, the outlet · Measured Aug 1, 2026
Website popularity band, not a count of readers or article views.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.